BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 20, 2007
View Archived Issues
Ziopharm Adds $31M For Clinical Oncology Pipeline
Ziopharm Oncology Inc. pulled in gross proceeds of $30.9 million in a private placement to advance ongoing clinical development of three lead cancer programs, two of which are expected enter pivotal testing this year. (BioWorld Today)
Read More
Inspire Pads Late-Stage Pipeline With License To InSite's AzaSite
Read More
In Irritable Bowel Syndrome Pain, A General Mechanism
Read More
FDA Says No Strings Attached To PDUFA At Public Meeting
Read More
Holiday Notice
Read More
GPC's Satraplatin NDA Done, Drug Could Launch This Year
Read More
Other News To Note
Read More
Appointments And Advancements
Read More